Moderna (MRNA) Stock Rises 3.61% Today, Coronavirus Vaccine Results Are Still Months Away
Moderna (MRNA) stock price has risen at the possibility of having a new coronavirus vaccine by the fall of this year. Trials are expected to have been completed in two months’ time.